[Brain natriuretic peptide, heart failure and elderly patients]

Area of Science:

• Biochemistry
• Clinical Diagnostics
• Geriatrics

Background:

• Natriuretic peptides, including B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP), are established biomarkers in clinical practice.
• Elevated levels of these peptides are associated with various cardiovascular conditions.
• Age and comorbidities like renal failure and hypertension can influence natriuretic peptide concentrations.

Purpose of the Study:

• To evaluate the diagnostic and prognostic utility of natriuretic peptides in the elderly population.
• To determine if age-related changes or comorbidities affect the clinical value of natriuretic peptides.
• To assess the preserved diagnostic accuracy of natriuretic peptides in elderly individuals.

Main Methods:

• Review of existing clinical data and studies on natriuretic peptides (BNP, NT-proBNP).
• Analysis of peptide levels in relation to age and common comorbidities (renal failure, hypertension).
• Comparative assessment of diagnostic performance in elderly versus younger cohorts.

Main Results:

• Natriuretic peptide levels, particularly BNP and NT-proBNP, can increase with age.
• Comorbidities such as renal failure and hypertension further impact peptide concentrations, necessitating age adjustments.
• Despite potential increases, the diagnostic value of natriuretic peptides is maintained in elderly patients.

Conclusions:

• Natriuretic peptides remain valuable diagnostic and prognostic tools in elderly patients.
• Age and comorbidities necessitate careful interpretation and potential adjustments for natriuretic peptide levels.
• The diagnostic utility of natriuretic peptides is preserved across different age groups, including the elderly.